CompletedNCT00388167

Acetato de Caspofungin (Cancidas®) in the Treatment of Fungal Infection

Studying Aspergillosis

Last synced from ClinicalTrials.gov May 4, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: PETHEMA Foundation
Principal Investigator: Miguel Angel Sanz, Dr
Hospital La Fe
Intervention: Caspofungin(drug)
Enrollment: 320 enrolled
Eligibility: 18 years · All sexes
Timeline: 2004 – 2008

Study locations (27)

Hospital General de Alicante, Alicante, Alicante, Spain
Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain
Hospital Clínico y Provincial de Barcelona, Barcelona, Barcelona, Spain
Hospital de la Santa Creu i Sant Pau, Barcelona, Barcelona, Spain
Hospital vall d'Hebrón, Barcelona, Barcelona, Spain
Institut Català d'Oncología, L'Hospitalet de Llobregat, Barcelona, Spain
Xarxa assistencial de Manresa, Manresa, Barcelona, Spain
Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain
Hospital general de Castellón, Castelló, Castellón, Spain
Hospital Puerta del Mar, Cadiz, Cádiz, Spain
Complejo Hospitalario Reina Sofía, Córdoba, Córdoba, Spain
Hospital Universitario Virgen de las Nieves, Granada, Granada, Spain
Hospital Juan Canalejo, A Coruña, La Coruña, Spain
Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, La Coruña, Spain
. Hospital Clínico Universitario Virgen de la Victoria, Málaga, Málaga, Spain
+12 more locations on ClinicalTrials.gov

Collaborators

GTEI · SEMICYUC

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00388167 on ClinicalTrials.gov

Other trials for Aspergillosis

Additional recruiting or active studies for the same condition.

See all trials for Aspergillosis →

← Back to all trials